A comparative-descriptive analysis of clinical characteristics in 2019-coronavirus-infected children and adults.
2019 novel coronavirus
clinical manifestations
comparative analysis
differences between children and adults
laboratory parameters
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
21
03
2020
revised:
27
03
2020
accepted:
29
03
2020
pubmed:
7
4
2020
medline:
29
12
2020
entrez:
7
4
2020
Statut:
ppublish
Résumé
Acute respiratory disease caused by 2019 novel coronavirus (2019-nCoV) has rapidly spread throughout China. Children and adults show a different clinical course. The purpose of the current study is to comparatively analyze the clinical characteristics of 2019-nCoV infection in children and adults and to explore the possible causes for the discrepancies present. The medical records of 25 adults and 7 children confirmed cases of 2019-2019-nCoV acute respiratory diseases were reviewed retrospectively. All children were family clusters. The total adult patients were differentiated into the local residents of Wuhan, a history of travel to Wuhan and direct contact with people from Wuhan. The numbers were 14 (56%), 10 (40%), and 1 (4%), respectively. The median incubation period of children and adults was 5 days (ranged, 3-12 days) and 4 days (ranged, 2-12 days), respectively. Diarrhoea and/or vomiting (57.1%) were demic by World Health Organiza more common in children, whereas for adults it was myalgia or fatigue (52%). On admission, the percentage of children having pneumonia (5%, 71.4%) was roughly the same as adults (20%, 80%). A total of 20% of adults had leucopoenia, but leukocytosis was more frequently in children (28.6%, P=.014). A higher number of children had elevated creatine kinase isoenzyme (57.1% vs 4%, P=.004). Antiviral therapy was given to all adult patients but to none of the children. In summary, knowledge of these differences between children and adults will not only be helpful for the clinical diagnosis of 2019-nCoV disease, but also for a future discussion on age-specific coronavirus infection.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1596-1602Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506.
WHO main website. https://www.who.int. (Accessed 29 February 2020).
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-273.
Gralinski LE, Menachery VD. Return of the coronavirus 2019-nCoV. Viruses. 2020;12(2):135.
WHO main website. https://www.who.int. (Accessed 5 February 2020).
Chinese Center For Disease Control and Prevention main website. http://www.nhc.gov.cn. (Accessed 28 February 2020).
Zeng LK, Tao XW, Yuan WH, et al. First case of neonate infected with novel coronavirus pneumonia in China. Chinese. J Pediatr. 2020;58.https://rs.yiigle.com/yufabiao/1182000.htm
Epidemiology group, New coronavirus pneumonia emergency response mechanism, Chinese CDC. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin J Epidemiol. 2020,41(2):145-151.
Chen F, Liu ZSh, Zhang FR, et al. Frist case of severe childhood novel coronavirus pneumonia in China. Chinese J Pediatr. 2020;58. E005.
Yang Y LQ, Liu M, et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. MexRxiv preprint 2020.
Diagnosis and Treatment of Pneumonia Caused by 2019-nCoV (version 5). http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml. (Accessed 5 February 2020).
Chen Z, Fu J, Shu Q, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr. 2020. https://doi.org/10.1007/s12519-020-00345-5
Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang Z. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA. 2020;323(13):1313-1314.
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-513.
Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New Engl J Med. 2020;382:1119-1207.
Guan W-j, Ni Z-y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. New Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2002032
Shen KL, Yang YH. Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue. World J Pediatr. 2020. https://doi.org/10.1007/s12519-020-00344-6
Fang D, Ma JD, Guan JL, et al. Manifestations of digestive system in hospitalized patients with novel coronavirus pneumonia in Wuhan, China: a single-center, descriptive study. Chin J Dig. 2020;40(2020-02-23), https://rs.yiigle.com/yufabiao/1182632.htm
Zhang H, Kang ZJ, Xu D, et al. The digestive system is a potential route of 2019-nCoV infection: a bioinformatics analysis based on single-cell transcriptomes. BioRxiv. 2020. https://doi.org/10.1101/2020.01.30.927806
Chen H, Xuan B, Yan Y, et al. Profiling ACE2 expression in colon tissue of healthy adults and colorectal cancer patients by single-cell transcriptome analysis. medRxiv. 2020. https://doi.org/10.1101/2020.02.15.20023457
National Recommendations for Diagnosis and Treatment of pneumonia caused by 2019-nCoV (the 4th edition). National Health Commission and National Administrative Office of Chinese Tradition Medicine. https://www.nhc.gov.cn/xcs/zheng_cwj/202001/42945_63ed3_5b432_09b31_739bd_0785e_67/files/7a930_91112_67475_a99d4_30696_2c8bf_78.pdf. (Accessed 29 January 2020).
Su B, Wang Y, Zhou R, et al. Efficacy and tolerability of lopinavir/ritonavir- and efavirenz-based initial antiretroviral therapy in HIV-1-infected patients in a tertiary care hospital in Beijing, China. Front Pharmacol. 2019;10:1472.
Chu CM, Cheng VC, Hung IF, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59(3):252-256.
Wilder-Smith A, Freedman DO. Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. J Travel Med. 2020;27(2), https://doi.org/10.1093/jtm/taaa02
Zhu W, Xie K, Lu H, Xu L, Zhou S, Fang S. Initial clinical features of suspected Coronavirus Disease 2019 in two emergency departments outside of Hubei, China. J Med Virol. 2020. https://doi.org/10.1002/jmv.25763